TIANJIN PHAR.DA REN S YC1
TIANJIN PHAR.DA REN S YC1
Share · CNE100000924 · A0Q272 (XSES)
Overview
No Price
Closing Price XSES 21.10.2025: 2,73 USD
21.10.2025 01:10
1 day
-
1 week
-
1 month
-
3 months
-
6 months
-
Year to date
-
1 year
-
2 years
-
3 years
-
4 years
-
5 years
-
10 years
-
20 years
-
Max
-
Current Prices from TIANJIN PHAR.DA REN S YC1
ExchangeTickerCurrencyLast TradePriceDaily Change
XSES: SGX
SGX
T14.SI
USD
21.10.2025 01:10
2,73 USD
0,010 USD
+0,37 %
Invested Funds

The following funds have invested in TIANJIN PHAR.DA REN S YC1:

Fund
iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF USD (Dist)
Vol. in million
27,15
Percentage (%)
0,03 %
Company Profile for TIANJIN PHAR.DA REN S YC1 Share
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceutical consultancy services. The company sells its medicinal products under its own brand to the wholesalers; and purchases medicinal products under other brands from distributors and sells these to other wholesalers. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was incorporated in 1992 and is based in Tianjin, the People's Republic of China.

Company Data

Name TIANJIN PHAR.DA REN S YC1
Company Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Website https://www.zhongxinp.com
Primary Exchange XSES Frankfurt
WKN A0Q272
ISIN CNE100000924
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Lei Wang
Market Capitalization 4 Mrd.
Country China
Currency EUR
Employees 4,6 T
Address Zhong Xin Mansion, 300193 Tianjin
IPO Date 2000-01-03

Ticker Symbols

Name Symbol
Frankfurt 2TZ.F
SGX T14.SI
More Shares
Investors who hold TIANJIN PHAR.DA REN S YC1 also have the following shares in their portfolio:
CLOSE BROTHERS FINANCE PLC 1.437% NTS 12/04/24
CLOSE BROTHERS FINANCE PLC 1.437% NTS 12/04/24 Bond
ISHS DL TREASURY BD DL D
ISHS DL TREASURY BD DL D ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025